Phase III / IV , Randomized, Fifty‐Two –Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus-Reference-Cited by-同舟云学术

Phase III / IV , Randomized, Fifty‐Two –Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus

Published:2021-12-09 Issue:1 Volume:74 Page:112-123
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Ginzler Ellen¹,Guedes Barbosa Luiz Sergio²,D'Cruz David³,Furie Richard⁴^ORCID,Maksimowicz‐McKinnon Kathleen⁵,Oates James⁶,Santiago Mittermayer Barreto⁷^ORCID,Saxena Amit⁸,Sheikh Saira⁹^ORCID,Bass Damon L.¹⁰,Burriss Susan W.¹⁰,Gilbride Jennifer A.¹¹,Groark James G.¹⁰,Miller Michelle¹⁰,Pierce Amy¹²,Roth David A.¹⁰,Ji Beulah¹³

Affiliation:

1. State University of New York (SUNY) Downstate Health Sciences University New York

2. Núcleo de Terapia Especializada em Cancerologia (NUTEC) Cuiaba Brazil

3. Guy's Hospital London UK

4. Northwell Health Great Neck New York

5. Henry Ford Health System Detroit Michigan

6. Medical University of South Carolina and Ralph H. Johnson VA Medical Center Charleston South Carolina

7. Escola Bahiana de Medicina e Saúde Pública Salvador Bahia Brazil

8. NYU Grossman School of Medicine New York

9. University of North Carolina Chapel Hill

10. GlaxoSmithKline Collegeville Pennsylvania

11. GlaxoSmithKline Stevenage UK

12. ViiV Healthcare, Research Triangle North Carolina

13. GlaxoSmithKline Uxbridge UK

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41900

Reference32 articles.

1. Innate Immune Cells' Contribution to Systemic Lupus Erythematosus

2. Lupus Nephritis: Current Treatment Paradigm and Unmet Needs

3. Epidemiology of systemic lupus erythematosus: an update

4. Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus

5. The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus [review];Lewis MJ;Rheumatology (Oxford),2017

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokines in lupus;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Lupus and other autoimmune diseases: Epidemiology in the population of African ancestry and diagnostic and management challenges in Africa;Journal of Allergy and Clinical Immunology: Global;2024-11

3. Inhibition of GRK2 ameliorates the pristane-induced mouse SLE model by suppressing plasma cells differentiation;International Immunopharmacology;2024-09

4. Neuropsychiatric involvement in systemic lupus erythematosus contributes to organ damage beyond the nervous system: a post-hoc analysis of 5 phase III randomized clinical trials;Rheumatology International;2024-08-08

5. Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials;The Lancet Rheumatology;2024-08